David Starks

1.0k total citations
42 papers, 542 citations indexed

About

David Starks is a scholar working on Oncology, Reproductive Medicine and Obstetrics and Gynecology. According to data from OpenAlex, David Starks has authored 42 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 18 papers in Reproductive Medicine and 10 papers in Obstetrics and Gynecology. Recurrent topics in David Starks's work include Ovarian cancer diagnosis and treatment (17 papers), Endometrial and Cervical Cancer Treatments (8 papers) and Cancer Cells and Metastasis (6 papers). David Starks is often cited by papers focused on Ovarian cancer diagnosis and treatment (17 papers), Endometrial and Cervical Cancer Treatments (8 papers) and Cancer Cells and Metastasis (6 papers). David Starks collaborates with scholars based in United States, Canada and Spain. David Starks's co-authors include Amanda N. Fader, Pedro F. Escobar, Tommaso Falcone, Mohamed A. Bedaiwy, William W. Hurd, Nina Desai, Sherif A. El‐Nashar, Hesham Al-Inany, Matthew D. Barber and Ahmed M Abou-Setta and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

David Starks

40 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Starks United States 11 239 203 149 120 117 42 542
Mihai Meirovitz Israel 15 190 0.8× 277 1.4× 109 0.7× 76 0.6× 157 1.3× 44 558
Michael J. Sundborg United States 7 299 1.3× 167 0.8× 243 1.6× 41 0.3× 75 0.6× 19 433
Wayne A. Christopherson United States 13 203 0.8× 205 1.0× 118 0.8× 57 0.5× 90 0.8× 24 474
Kornkanok Sukpan Thailand 17 211 0.9× 202 1.0× 254 1.7× 60 0.5× 116 1.0× 49 617
Mauro Marchionni Italy 16 205 0.9× 395 1.9× 190 1.3× 83 0.7× 68 0.6× 36 739
Annalisa Pieralli Italy 15 174 0.7× 167 0.8× 167 1.1× 73 0.6× 110 0.9× 41 731
Dieter Grab Germany 13 425 1.8× 332 1.6× 187 1.3× 93 0.8× 83 0.7× 25 770
Ho Sun Choi South Korea 16 138 0.6× 147 0.7× 261 1.8× 78 0.7× 60 0.5× 38 575
Hiroaki Negishi Japan 15 255 1.1× 356 1.8× 139 0.9× 173 1.4× 96 0.8× 31 761
Kristopher J. Kimball United States 13 105 0.4× 176 0.9× 107 0.7× 37 0.3× 189 1.6× 28 567

Countries citing papers authored by David Starks

Since Specialization
Citations

This map shows the geographic impact of David Starks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Starks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Starks more than expected).

Fields of papers citing papers by David Starks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Starks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Starks. The network helps show where David Starks may publish in the future.

Co-authorship network of co-authors of David Starks

This figure shows the co-authorship network connecting the top 25 collaborators of David Starks. A scholar is included among the top collaborators of David Starks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Starks. David Starks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Hamilton, Erika, Hyo S. Han, Kevin Kalinsky, et al.. (2025). Initial phase 1 dose escalation data for emiltatug ledadotin (Emi-Le), a novel B7-H4-directed dolasynthen antibody-drug conjugate.. Journal of Clinical Oncology. 43(16_suppl). 3009–3009. 1 indexed citations
4.
Street, Daron, David Starks, Haider Mahdi, et al.. (2024). A phase I/II study of maplirpacept in combination with pegylated liposomal doxorubicin (PLD) in patients with platinum-resistant ovarian cancer (OC): Phase 1 results.. Journal of Clinical Oncology. 42(16_suppl). e17546–e17546. 2 indexed citations
5.
Moore, Kathleen N., Ana Oaknin, Isabelle Ray‐Coquard, et al.. (2024). GOG-3084: A phase II trial of ADP-A2M4CD8 TCR-T cell therapy, alone or in combination with nivolumab, among patients with recurrent ovarian cancers. Gynecologic Oncology. 190. S281–S282. 1 indexed citations
6.
De, Pradip, et al.. (2023). Characterization and Clinical Relevance of Endometrial CAFs: Correlation between Post-Surgery Event and Resistance to Drugs. International Journal of Molecular Sciences. 24(7). 6449–6449. 4 indexed citations
7.
Moore, Kathleen N., Ana Oaknin, Isabelle Ray‐Coquard, et al.. (2023). #24 A phase 2 study (GOG-3084) OF ADP-A2M4CD8 TCR T-cell therapy, alone or in combination with nivolumab, in patients with recurrent ovarian cancers. A407.2–A408. 1 indexed citations
8.
De, Pradip, Jennifer C. Aske, Xiaoqian Lin, et al.. (2023). Tumor-TME Bipartite Landscape of PD-1/PD-L1 in Endometrial Cancers. International Journal of Molecular Sciences. 24(13). 11079–11079. 2 indexed citations
9.
Richardson, Debra J., Jill Tseng, Theresa L. Werner, et al.. (2022). 33 UPLIFT (ENGOT-ov67/GOG-3048) a pivotal cohort of upifitamab rilsodotin (XMT-1536; UpRi), a NaPi2b-directed antibody drug conjugate (ADC) in platinum-resistant ovarian cancer. Gynecologic Oncology Reports. 44. S16–S17. 2 indexed citations
10.
Liu, Yihua, Zachary Weber, F. Anthony San Lucas, et al.. (2018). Assessing inter-component heterogeneity of biphasic uterine carcinosarcomas. Gynecologic Oncology. 151(2). 243–249. 12 indexed citations
11.
Starks, David, et al.. (2014). Mexican Cervical Cancer Screening Study II. Journal of Lower Genital Tract Disease. 18(4). 333–337. 7 indexed citations
12.
Jiang, Wei, Santosh K. Ghosh, Rebecca Flyckt, et al.. (2012). Bacterial Colonization and Beta Defensins in the Female Genital Tract in HIV Infection. Current HIV Research. 10(6). 504–512. 11 indexed citations
13.
Bedaiwy, Mohamed A., David Starks, William W. Hurd, & Pedro F. Escobar. (2012). Laparoendoscopic Single-Site Surgery in Patients with Benign Adnexal Disease: A Comparative Study. Gynecologic and Obstetric Investigation. 73(4). 294–298. 14 indexed citations
14.
Starks, David, et al.. (2011). Management of a Type I Hypersensitivity Reaction to IV Etoposide in a Woman with a Yolk Sac Tumor: A Case Report. Case Reports in Obstetrics and Gynecology. 2011. 1–2. 4 indexed citations
15.
Escobar, Pedro F., et al.. (2010). Laparoendoscopic single-site and natural orifice surgery in gynecology. Fertility and Sterility. 94(7). 2497–2502. 42 indexed citations
16.
Escobar, Pedro F., et al.. (2010). Single-port risk-reducing salpingo-oophorectomy with and without hysterectomy: Surgical outcomes and learning curve analysis. Gynecologic Oncology. 119(1). 43–47. 70 indexed citations
17.
Bedaiwy, Mohamed A., Ahmed M Abou-Setta, Nina Desai, et al.. (2010). Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis. Fertility and Sterility. 95(3). 906–914.e4. 109 indexed citations
18.
Fader, Amanda N., Vivian von Gruenigen, Heidi Gibbons, et al.. (2008). Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian cancer patients. Gynecologic Oncology. 109(1). 33–38. 28 indexed citations
19.
Cerini, Fabrice, Alan Landay, Michael M. Lederman, et al.. (2008). Chemokine Analogues Show Suitable Stability for Development as Microbicides. JAIDS Journal of Acquired Immune Deficiency Syndromes. 49(5). 472–476. 30 indexed citations
20.
Moawad, Nash S., et al.. (2008). Ectopic Ovarian Teratoma of the Uterosacral Ligament Associated with a Large Ovarian Dermoid. Journal of Minimally Invasive Gynecology. 15(5). 523–524. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mihai Meirovitz Breakdown of academic impact, for papers by Michael J. Sundborg Breakdown of academic impact, for papers by Wayne A. Christopherson Breakdown of academic impact, for papers by Kornkanok Sukpan Breakdown of academic impact, for papers by Mauro Marchionni Breakdown of academic impact, for papers by Annalisa Pieralli Breakdown of academic impact, for papers by Dieter Grab Breakdown of academic impact, for papers by Ho Sun Choi Breakdown of academic impact, for papers by Hiroaki Negishi Breakdown of academic impact, for papers by Kristopher J. Kimball
Rankless by CCL
2026